Literature DB >> 6809131

Regression of carcinoid tumour with cyproheptadine.

A L Harris, I E Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6809131      PMCID: PMC1499232          DOI: 10.1136/bmj.285.6340.475

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  A comparison of the effects of bradykinin, 5-hydroxytryptamine and histamine on the hepatic arterial and portal venous vascular beds of the dog: histamine H1 and H2-receptor populations.

Authors:  P D Richardson; P G Withrington
Journal:  Br J Pharmacol       Date:  1977-05       Impact factor: 8.739

2.  Carcinoid tumors: pharmacological therapy.

Authors:  G J Hill
Journal:  Oncology       Date:  1971       Impact factor: 2.935

3.  Management of carcinoid syndrome.

Authors:  P Bonomi; C Hovey; J R Dainauskas; R Slayton; J Wolter
Journal:  Med Pediatr Oncol       Date:  1979

4.  Treatment of carcinoid liver metastases by hepatic-artery embolisation.

Authors:  D J Allison; I M Modlin; W J Jenkins
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

5.  Influence of biogenic amines on the growth of xenografted human colorectal carcinomas.

Authors:  P J Tutton; G G Steel
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

  5 in total
  3 in total

1.  Small bowel carcinoid tumors.

Authors:  H F Woods; N D Bax; J A Smith
Journal:  World J Surg       Date:  1985-12       Impact factor: 3.352

2.  Histamine as an intermediate growth factor in genesis of gastric ECLomas associated with hypergastrinemia in mastomys.

Authors:  I M Modlin; R R Kumar; C J Soroka; H Ahlman; O Nilsson; J R Goldenring
Journal:  Dig Dis Sci       Date:  1994-07       Impact factor: 3.199

Review 3.  OPALS: A New Osimertinib Adjunctive Treatment of Lung Adenocarcinoma or Glioblastoma Using Five Repurposed Drugs.

Authors:  Richard E Kast; Marc-Eric Halatsch; Rafael Rosell
Journal:  Cells       Date:  2021-05-10       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.